Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
2.18B
-
Number of holders
-
1365
-
Total 13F shares, excl. options
-
133M
-
Shares change
-
-4.33M
-
Total reported value, excl. options
-
$16.1B
-
Value change
-
-$491M
-
Put/Call ratio
-
1
-
Number of buys
-
587
-
Number of sells
-
-547
-
Price
-
$121.01
Significant Holders of NOVARTIS AG - Ordinary Shares (NVS) as of Q2 2025
1,473 filings reported holding NVS - NOVARTIS AG - Ordinary Shares as of Q2 2025.
NOVARTIS AG - Ordinary Shares (NVS) has 1,365 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 133M shares
of 2.18B outstanding shares and own 6.11% of the company stock.
Largest 10 shareholders include Dodge & Cox (10.6M shares), PRIMECAP MANAGEMENT CO/CA/ (10.4M shares), DIMENSIONAL FUND ADVISORS LP (9.06M shares), MORGAN STANLEY (7.56M shares), Fisher Asset Management, LLC (7.12M shares), LOOMIS SAYLES & CO L P (5.58M shares), BANK OF AMERICA CORP /DE/ (4.53M shares), FRANKLIN RESOURCES INC (4.24M shares), GOLDMAN SACHS GROUP INC (2.54M shares), and WELLINGTON MANAGEMENT GROUP LLP (2.5M shares).
This table shows the top 1365 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.